Crossmark

Dose reduction and discontinuation due to the combination of CDK4/6 inhibitors and endocrine drugs: a systematic review and meta-analysis

Published Online: 2024-09-13

Published Print: 2024-12

Authors

Yang, Ping

Zhang, Hengheng

Wu, Meijie

Zhao, Fuxing

Wang, Miaozhou

Zhao, Jiuda

Zhao, Yi
License Information

Text and Data Mining valid from 2024-09-13

Version of Record valid from 2024-09-13
More Information

Article History

Received: 16 July 2024

Accepted: 2 September 2024

First Online: 13 September 2024

Declarations

:

: The authors declare no competing interests.

Document is current